New Alzheimer’s drug approved in U.S. despite concerns about effectiveness – CBC.ca

U.S. government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease.

Click here to view the original article.